In ATM, one missense mutation, p.Val2424Gly (c.7271T>G) confers a higher risk of breast cancer than truncating ATM variants (up to 52% in one study; 95% CI 28–80%) and may do so by acting as a dominant negative [108,109,110]. Here, ATM is linked to breast cancer.